C12-113
Based on 1 Customer Validation
C12-113 is a lipidoid delivery agent that can be used to transfect siRNA into cells. C12-113 can also be combined with other lipids to form lipid nanoparticles (LNPs) for the delivery of mRNA encoding the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mice.
The product specifications provided below refer solely to the active content of C12-113.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.67%
- CAS. Nr.: 1220890-27-6
- Formel: C53H111N3O4
- Molecular Weight:854.47
-
Speicherung:
Solution, -20°C, 2 years
Biologische Aktivität
Beschreibung
The product specifications provided below refer solely to the active content of C12-113.
Chemical Information
-
CAS. Nr. 1220890-27-6
-
Appearance Liquid
-
Molecular Weight 854.47
-
Formel C53H111N3O4
-
Color Colorless to light yellow
-
SMILES
OC(CCCCCCCCCC)CN(CC(CCCCCCCCCC)O)CCN(CCN(CC(CCCCCCCCCC)O)CC(CCCCCCCCCC)O)C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Solution, -20°C, 2 years
Lösungsmittel & Löslichkeit
In Vitro:
Ethanol : 10 mg/mL (11.70 mM; Need ultrasonic)
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Reinheit & Dokumentation
-
Data Sheet (270 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
Verweise
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Lipid Nanoparticles: Key Nucleic Acid Delivery Vectors
Lipid nanoparticles (LNPs) are the most clinically advanced non-viral delivery systems for nucleic acid therapeutics and enable the in vivo delivery of mRNA, siRNA, and other genetic cargos.
2026-06-18
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Ethanol | 1 mM | 1.1703 mL | 5.8516 mL | 11.7032 mL | 29.2579 mL |
| 5 mM | 0.2341 mL | 1.1703 mL | 2.3406 mL | 5.8516 mL | |
| 10 mM | 0.1170 mL | 0.5852 mL | 1.1703 mL | 2.9258 mL |